Immunoprecise Antibodies Ltd (IPA) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jan 31 2026 to Jan 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immunoprecise Antibodies Ltd   (NASDAQ: IPA)


Immunoprecise Antibodies Ltd 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Immunoprecise Antibodies Ltd 's ROA in the third quarter of 2026?
Immunoprecise Antibodies Ltd recorded a cumulative net loss of $-9 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -31.35%.

However, within the Healthcare sector 744 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2025 from to 4275.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jan 31 2026)
III. Quarter		 (Oct 31 2025)
II. Quarter		 (Jul 31 2025)
I. Quarter		 (Apr 30 2025)
IV. Quarter		 (Jan 31 2025)
III. Quarter
Y / Y Total Assets Change -29.95 % -59.45 % -31.58 % -46 % 6.98 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -9 -21 -40 -39 -38
Return On Assets (TTM) -31.35 % -66.95 % -103.28 % -94.2 % -77.8 %
IPA's Total Ranking # 4275 # # # # 4386
Total Assets (TTM) in million 32 19 29 32 46
Seq. Total Assets Change 72.76 % -36.7 % -8.56 % -29.95 % 0 %
Seq. Net Income Change - - - - -

IPA's 5 Years Annual ROA >> Back to IPA Management Effectiveness >> Compare IPA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 335
Sector # 745
Overall # 4441

Return On Assets Statistics
High Average Low
-18.24 %
-41.28 %
-67.43 %
(Apr 30 2022)   (Apr 30 2025)



  News about Immunoprecise Antibodies Ltd Return on Assets ROA

ImmunoPrecise Antibodies Ltd. Achieves Nasdaq Compliance and Demonstrates Robust Market Performance

In recent developments within the biopharmaceutical sector, ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a pioneering company at the confluence of technology, bioinformatics, and biological intelligence, has regained compliance with the Nasdaq Stock Market s minimum bid price requirement. This achievement signifies a critical milestone in the company s growth trajectory and reflects its resilience and capacity to adhere to stringent financial regulations. Regaining Nasdaq Compliance: ImmunoPrecise received formal notification from The Nasdaq Stock Market LLC, confirming that the company had met the relevant criteria stipulated in Nasdaq Listing Rule 5550(a)(2). This rule necessitates that a listed company s stock maintains a minimum bid price of $1.00 per share for ten consecutive business days. The notice, dated July 11, 2025, highlights ImmunoPrecise s successful adherence to this requirement, thereby maintaining its listing on Nasdaq.



Financial Statements
Immunoprecise Antibodies Ltd 's Assets $ 32 million IPA's Balance sheet
Immunoprecise Antibodies Ltd 's Income $ -3 million Quarterly IPA's Income Statement
IPA's Income by Division See IPA's Income by Division



Annual Return On Assets (Apr 30 2025)
FY 2025		 (Apr 30 2024)
FY 2024		 (Apr 30 2023)
FY 2023		 (Apr 30 2022)
FY 2022		 (Apr 30 2020)
FY 2021
Y / Y Total Assets Change -29.95 % -22.91 % -23.66 % 298.39 % -
Total Assets in million 32 46 60 78 20
Y / Y Net Income Change - - - - -
Net Income in million -22 -21 -20 -13 -4
Annual Return On Assets -67.43 % -45.3 % -34.13 % -17.06 % -18.89 %

IPA's 5 Years Annual ROA >> Back to IPA Management Effectiveness >> Compare IPA ROA to its Competitors



More Return On Assets Ratios
IPA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IPA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IPA's Competitors
Subscribers only: Roa for Immunoprecise Antibodies Ltd 's Suppliers
Subscribers only: Return On Assets for IPA's Customers

You may also want to know
IPA's Roi IPA's Inventory Turnover Ratio IPA's Growth Rates IPA's Dividend Comparisons
IPA's Profitability Ratios IPA's Asset Turnover Ratio IPA's Dividend Growth
IPA's Roe IPA's Valuation Ratios IPA's Financial Strength Ratios IPA's Dividend Payout Ratio



Companies with similar Return On Assets at Jan 31 2026, within Healthcare Sector ROA

Date modified: 2026-09-18T17:05:50+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.